FDA recall, , High risk
Handelnine Global Rheumacare Capsules
Rheumacare capsules contain lead.
Summary by Recall Canary from the FDA notice
What happened
HANDELNINE GLOBAL LLC of South Plainfield, New Jersey, recalled Rheumacare capsules, 30 count bottles, because the product was found to contain lead. The recall began December 22, 2025, and was added to the FDA's Enforcement Report on February 5, 2026. The product was manufactured in India by Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India, and distributed to one customer in NY.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the UPC and lot code listed under your product.
A UPC is the number printed under a barcode.
Rheumacare capsules
- UPC
- 8 904218 700313
- Lot code
- CAM040
- CAL079-N
Recall details
- Company began the recall
- Sold in
Product was distributed to one customer in NY.
- Company
- HANDELNINE GLOBAL LLCSouth Plainfield, New Jersey
- Hazard
- Manufacturing problem
- Risk
High risk
There is a reasonable chance that taking it could cause serious health problems or death.
FDA Class I recall · How risk is rated
- Event ID
- 98165
- Recall number
- D-0332-2026
- Quantity recalled
- 4 bottles /30 capsules each
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report
In FDA's weekly enforcement report
Classified by FDA
Listed on Recall Canary
